![](/img/cover-not-exists.png)
MA 02.02 Phase 2 Study of Pembrolizumab Plus CC-486 vs Pembrolizumab Plus Placebo in Previously Treated Patients with Advanced NSCLC
Levy, B., Giaccone, G., Besse, B., Felip, E., Garassino, M., Domine, M., Garrido, P., Piperdi, B., Aix, S. Ponce, Slepetis, R., Wu, X., Fandi, A., Paz-Ares, L.Volume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2017.09.452
Date:
November, 2017
File:
PDF, 445 KB
english, 2017